Litcius/Paper detail

Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study

Ariela Holmer, Jiyu Luo, Kirk Russ, Sarah Park, Jeong Yun Yang, Furkan U. Ertem, Jeffrey Dueker, Vu Q. Nguyen, Simon Hong, Cameron Zenger, Jordan E. Axelrad, Anthony Sofia, Jessica C. Petrov, Badr Al‐Bawardy, David Fudman, Ernesto M. Llano, Joseph Dailey, Sushrut Jangi, Nidah S. Khakoo, Oriana M. Damas, Edward L. Barnes, Frank I. Scott, Ryan C. Ungaro, Siddharth Singh

2023Clinical Gastroenterology and Hepatology19 citationsDOI

Topics & Concepts

MedicineCohortInternal medicineCancerHazard ratioMalignancyRetrospective cohort studyColorectal cancerOncologyCohort studyGastroenterologySurgeryConfidence intervalInflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesAcute Lymphoblastic Leukemia research
Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study | Litcius